Johan Richter

8.6k total citations
145 papers, 4.2k citations indexed

About

Johan Richter is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Johan Richter has authored 145 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 48 papers in Molecular Biology and 47 papers in Genetics. Recurrent topics in Johan Richter's work include Chronic Myeloid Leukemia Treatments (56 papers), Chronic Lymphocytic Leukemia Research (42 papers) and Eosinophilic Disorders and Syndromes (26 papers). Johan Richter is often cited by papers focused on Chronic Myeloid Leukemia Treatments (56 papers), Chronic Lymphocytic Leukemia Research (42 papers) and Eosinophilic Disorders and Syndromes (26 papers). Johan Richter collaborates with scholars based in Sweden, Germany and Finland. Johan Richter's co-authors include Stefan Karlsson, Tommy Andersson, Susanne Saußele, Andreas Hochhaus, Inge Olsson, Henrik Hjorth‐Hansen, Thoas Fioretos, Mats Ehinger, Maria Askmyr and Leif Stenke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Johan Richter

134 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Richter Sweden 36 1.7k 1.5k 1.2k 851 773 145 4.2k
Steffen Koschmieder Germany 37 2.4k 1.4× 2.8k 1.8× 1.7k 1.4× 730 0.9× 708 0.9× 222 5.2k
Ali G. Turhan France 37 2.0k 1.2× 1.5k 1.0× 1.4k 1.2× 1.0k 1.2× 473 0.6× 184 4.0k
Seth J. Corey United States 35 996 0.6× 1.4k 0.9× 484 0.4× 850 1.0× 1.1k 1.4× 114 3.5k
Clayton A. Smith United States 35 2.9k 1.7× 2.7k 1.8× 1.1k 1.0× 1.1k 1.3× 748 1.0× 129 5.5k
H. Scott Boswell United States 29 1.1k 0.6× 1.6k 1.1× 540 0.5× 594 0.7× 1.2k 1.6× 63 3.6k
Thierry Rème France 43 2.0k 1.1× 2.5k 1.7× 545 0.5× 1.4k 1.7× 1.8k 2.3× 102 5.4k
Danilo Perrotti United States 50 3.2k 1.9× 5.9k 3.8× 1.7k 1.4× 1.2k 1.5× 1.3k 1.6× 123 9.0k
Cornelius Miething Germany 28 863 0.5× 3.0k 1.9× 519 0.4× 1.5k 1.8× 1.2k 1.6× 68 5.1k
Ulrich Steidl United States 40 2.1k 1.2× 2.5k 1.7× 739 0.6× 810 1.0× 1.1k 1.5× 126 4.7k
Joop H. Jansen Netherlands 41 2.9k 1.6× 4.4k 2.9× 951 0.8× 1.1k 1.3× 1.4k 1.8× 155 7.0k

Countries citing papers authored by Johan Richter

Since Specialization
Citations

This map shows the geographic impact of Johan Richter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Richter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Richter more than expected).

Fields of papers citing papers by Johan Richter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Richter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Richter. The network helps show where Johan Richter may publish in the future.

Co-authorship network of co-authors of Johan Richter

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Richter. A scholar is included among the top collaborators of Johan Richter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Richter. Johan Richter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richter, Johan, et al.. (2025). Ore extensions of abelian groups with operators. Journal of Algebra. 686. 176–194.
2.
Wårdell, Karin, Johan Richter, & Peter Zsigmond. (2024). Cerebral Microcirculation: Progress and Outlook of Laser Doppler Flowmetry in Neurosurgery and Neurointensive Care. Microcirculation. 31(8). e12884–e12884.
3.
Dhapola, Parashar, Mikael N.E. Sommarin, Shamit Soneji, et al.. (2024). Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response. eLife. 12. 3 indexed citations
4.
Dhapola, Parashar, Mikael N.E. Sommarin, Shamit Soneji, et al.. (2023). Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response. eLife. 12. 3 indexed citations
5.
Ilander, Mette, Satu Mustjoki, Johan Richter, et al.. (2023). Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects. Annals of Hematology. 102(6). 1395–1408. 5 indexed citations
6.
Dahlén, Torsten, Gustaf Edgren, Per Ljungman, et al.. (2022). Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study. American Journal of Hematology. 97(4). 421–430. 8 indexed citations
7.
Lübking, Anna, Arta Dreimane, Fredrik Sandin, et al.. (2019). Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry. Bone Marrow Transplantation. 54(11). 1764–1774. 25 indexed citations
8.
Chapellier, Marion, Carl Högberg, Christina Orsmark‐Pietras, et al.. (2017). Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner. Leukemia. 32(3). 588–596. 35 indexed citations
9.
Thielen, Noortje, Johan Richter, Gisela Barbany, et al.. (2016). Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy. Clinical Cancer Research. 22(16). 4030–4038. 14 indexed citations
10.
Söderlund, Stina, Lisa Christiansson, Inger Persson, et al.. (2016). Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. Leukemia Research. 50. 95–103. 20 indexed citations
11.
Christiansson, Lisa, Stina Söderlund, Sara M. Mangsbo, et al.. (2015). The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses. Molecular Cancer Therapeutics. 14(5). 1181–1191. 57 indexed citations
12.
Skoglund, Karin, Johan Richter, Ulla Olsson‐Strömberg, et al.. (2015). In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia. Therapeutic Drug Monitoring. 38(2). 230–238. 10 indexed citations
13.
Flygare, Johan, Karin Olsson, Johan Richter, & Stefan Karlsson. (2008). Gene therapy of Diamond Blackfan anemia CD34+ cells leads to improved erythroid development and engraftment following transplantation. Experimental Hematology. 36(11). 1428–1435. 33 indexed citations
14.
Askmyr, Maria, Anders Fasth, & Johan Richter. (2008). Towards a better understanding and new therapeutics of osteopetrosis. British Journal of Haematology. 140(6). 597–609. 38 indexed citations
15.
Ågerstam, Helena, Henrik Lilljebjörn, Carin Lassen, et al.. (2007). Fusion gene‐mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome. Genes Chromosomes and Cancer. 46(7). 635–643. 41 indexed citations
16.
Johansson, M., Lina Jansson, Mats Ehinger, et al.. (2006). Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis. Experimental Hematology. 34(2). 242–249. 28 indexed citations
17.
Relander, Thomas, Ann Brun, Robert G. Hawley, Stefán Karlsson, & Johan Richter. (2001). Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium. The Journal of Gene Medicine. 3(3). 207–218. 20 indexed citations
18.
Richter, Johan, et al.. (2001). Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34+ progenitor cells. Leukemia. 15(12). 1914–1922. 26 indexed citations
19.
Fichtner, Iduna, Regina Reszka, Michael C. Rudolph, et al.. (1993). Carboplatin-liposomes as activators of hematopoiesis.. PubMed. 5(2). 65–74. 5 indexed citations
20.
Zetterberg, Eva & Johan Richter. (1993). Correlation between serum level of soluble L‐selectin and leukocyte count in chronic myeloid and lymphocytic leukemia and during bone marrow transplantation. European Journal Of Haematology. 51(2). 113–119. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026